Measuring potency for gene and cell therapies is not so clear-cut, and some companies have hit roadblocks in their submissions to regulatory agencies as a result. This webinar will look at ways to overcome that hurdle as well as challenges in relation to the "talent shortage" that exists because of the rapid growth of the industry, how collaboration is helping the sector progress, and more.
Chief business officer
Catalent Cell & Gene Therapy
VP scientific affairs & product development